187 related articles for article (PubMed ID: 38213031)
1. Genetically modified ZIKA virus as a microRNA-sensitive oncolytic virus against central nervous system tumors.
Novaes GM; Lima C; Longo C; Machado PH; Silva TP; Olberg GGO; Módolo DG; Pereira MCL; Santos TG; Zatz M; Lagares D; de Franco M; Ho PL; Bulstrode H; Okamoto OK; Kaid C
Mol Ther; 2024 Feb; 32(2):440-456. PubMed ID: 38213031
[TBL] [Abstract][Full Text] [Related]
2. Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
Kaid C; Goulart E; Caires-Júnior LC; Araujo BHS; Soares-Schanoski A; Bueno HMS; Telles-Silva KA; Astray RM; Assoni AF; Júnior AFR; Ventini DC; Puglia ALP; Gomes RP; Zatz M; Okamoto OK
Cancer Res; 2018 Jun; 78(12):3363-3374. PubMed ID: 29700002
[TBL] [Abstract][Full Text] [Related]
3. Effect of Serial Systemic and Intratumoral Injections of Oncolytic ZIKV
Ferreira RO; Granha I; Ferreira RS; Bueno HS; Okamoto OK; Kaid C; Zatz M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696533
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling Its Potential for Oncolytic Virotherapy.
Calderón-Peláez MA; Maradei Anaya SJ; Bedoya-Rodríguez IJ; González-Ipuz KG; Vera-Palacios D; Buitrago IV; Castellanos JE; Velandia-Romero ML
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675903
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Zika Virus: New Option for Glioblastoma Treatment.
Zhou C; Chen Q; Chen Y; Qin CF
DNA Cell Biol; 2023 Jun; 42(6):267-273. PubMed ID: 36350682
[TBL] [Abstract][Full Text] [Related]
6. Zika Virus: A New Therapeutic Candidate for Glioblastoma Treatment.
Francipane MG; Douradinha B; Chinnici CM; Russelli G; Conaldi PG; Iannolo G
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681654
[TBL] [Abstract][Full Text] [Related]
7. Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.
Kaid C; Madi RADS; Astray R; Goulart E; Caires-Junior LC; Mitsugi TG; Moreno ACR; Castro-Amarante MF; Pereira LR; Porchia BFMM; de Andrade TO; Landini V; Sanches DS; Pires CG; Tanioka RKO; Pereira MCL; Barbosa IN; Massoco CO; Ferreira LCS; Okamoto OK; Zatz M
Mol Ther; 2020 May; 28(5):1276-1286. PubMed ID: 32220305
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate.
Chen Q; Wu J; Ye Q; Ma F; Zhu Q; Wu Y; Shan C; Xie X; Li D; Zhan X; Li C; Li XF; Qin X; Zhao T; Wu H; Shi PY; Man J; Qin CF
mBio; 2018 Sep; 9(5):. PubMed ID: 30228241
[TBL] [Abstract][Full Text] [Related]
10. Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.
Victorio CBL; Novera W; Ganasarajah A; Ong J; Thomas M; Wu J; Toh HSY; Sun AX; Ooi EE; Chacko AM
J Transl Med; 2024 Feb; 22(1):126. PubMed ID: 38308299
[TBL] [Abstract][Full Text] [Related]
11. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
[TBL] [Abstract][Full Text] [Related]
12. The Propagation and Quantification of Two Emerging Oncolytic Viruses: Vesicular Stomatitis (VSV) and Zika (ZIKV).
Means RE; Roy SG; Katz SG
Methods Mol Biol; 2020; 2097():253-263. PubMed ID: 31776931
[TBL] [Abstract][Full Text] [Related]
13. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.
Nair S; Mazzoccoli L; Jash A; Govero J; Bais SS; Hu T; Fontes-Garfias CR; Shan C; Okada H; Shresta S; Rich JN; Shi PY; Diamond MS; Chheda MG
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232299
[TBL] [Abstract][Full Text] [Related]
14. Zika virus has oncolytic activity against glioblastoma stem cells.
Zhu Z; Gorman MJ; McKenzie LD; Chai JN; Hubert CG; Prager BC; Fernandez E; Richner JM; Zhang R; Shan C; Tycksen E; Wang X; Shi PY; Diamond MS; Rich JN; Chheda MG
J Exp Med; 2017 Oct; 214(10):2843-2857. PubMed ID: 28874392
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.
Leber MF; Bossow S; Leonard VH; Zaoui K; Grossardt C; Frenzke M; Miest T; Sawall S; Cattaneo R; von Kalle C; Ungerechts G
Mol Ther; 2011 Jun; 19(6):1097-106. PubMed ID: 21468006
[TBL] [Abstract][Full Text] [Related]
16. Zika virus-based immunotherapy enhances long-term survival of rodents with brain tumors through upregulation of memory T-cells.
Crane AT; Chrostek MR; Krishna VD; Shiao M; Toman NG; Pearce CM; Tran SK; Sipe CJ; Guo W; Voth JP; Vaid S; Xie H; Lu WC; Swanson W; Grande AW; Schleiss MR; Bierle CJ; Cheeran MC; Low WC
PLoS One; 2020; 15(10):e0232858. PubMed ID: 33002018
[TBL] [Abstract][Full Text] [Related]
17. Lassa-vesicular stomatitis chimeric virus safely destroys brain tumors.
Wollmann G; Drokhlyansky E; Davis JN; Cepko C; van den Pol AN
J Virol; 2015 Jul; 89(13):6711-24. PubMed ID: 25878115
[TBL] [Abstract][Full Text] [Related]
18. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus.
Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M
Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889
[No Abstract] [Full Text] [Related]
19. Zika Virus with Increased CpG Dinucleotide Frequencies Shows Oncolytic Activity in Glioblastoma Stem Cells.
Trus I; Berube N; Jiang P; Rak J; Gerdts V; Karniychuk U
Viruses; 2020 May; 12(5):. PubMed ID: 32466170
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy.
Ruiz AJ; Hadac EM; Nace RA; Russell SJ
J Virol; 2016 Apr; 90(8):4078-4092. PubMed ID: 26865716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
